In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Collegium Pharmaceutical, Inc.. Trade Record

NASDAQ:COLL Collegium Pharmaceutical, Inc. stock gains 20.31% Exit Feb 2, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart COLL Jan 10, 2018, priceSeries
About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. It offers Xtampza, an oral formulation of oxycodone, for the management of pain. The company also develops Onsolis, a transmucosal immediate-release fentanyl film indicated for the management of breakthrough pain in cancer patients 18 years of age and older. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Jan 10, 2018
Entry Price
18.91
Sell Date
Feb 2, 2018
Sell Price
22.75
Net Gain
20.31%
Hold Time
16 Trading Days